Abstract
Background: Early exposure to allergens through a defect skin barrier has been proposed as a mechanism for inducing sensitization and development of allergic diseases. We hypothesized that early-onset, severe atopic dermatitis (AD) is associated with development of aeroallergen sensitization and allergic rhinitis. Methods: We included 368 children from the Copenhagen Prospective Studies on Asthma in Childhood2000 (COPSAC2000) at-risk mother-child cohort. AD was diagnosed prospectively based on Hanifin&Rajka's criteria and severity assessed using the Scoring Atopic Dermatitis (SCORAD) index. Early-onset AD was defined as debut ≤1 year, late-onset as debut from 1–6 years. Aeroallergen sensitization and allergic rhinitis were diagnosed at ages 6–7 and 12 years. Associations between early-onset and late-onset AD and allergy endpoints were calculated using general estimating equations (GEE) models to compute the overall odds ratios (OR) for both time points. Results: Early-onset AD (yes/no) and severity (SCORAD) were associated with development of aeroallergen sensitization during childhood; GEE OR = 1.68 [1.08; 2.62], p =.02 and 1.08 [1.03; 1.12], p <.001, whereas late-onset AD showed a borderline significant association and late-onset severity showed no association; GEE OR = 1.65 [0.92; 2.94], p =.08 and 1.01 [0.97; 1.06], p =.55. The same trend was seen for allergic rhinitis with significant association between early-onset AD and allergic rhinitis; GEE OR = 1.56 [1.01; 2.41], p =.04 and severity; GEE OR = 1.09 [1.05; 1.13], p <.001, whereas late-onset AD showed no association. The effects on sensitization and rhinitis of early-onset versus late-onset AD severity were significantly different: p-interactionsensitization =.03 and p-interactionrhinitis <.01. Conclusion: Increasing severity of early-onset AD, but not late-onset AD, associates with aeroallergen sensitization and allergic rhinitis later in childhood.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Allergy: European Journal of Allergy and Clinical Immunology |
| Vol/bind | 77 |
| Udgave nummer | 4 |
| Sider (fra-til) | 1254-1262 |
| ISSN | 0105-4538 |
| DOI | |
| Status | Udgivet - 2022 |
Bibliografisk note
Funding Information:All funding received by COPSAC is listed on www.copsac.com . The Lundbeck Foundation (Grant no R16‐A1694); The Ministry of Health (Grant no 903516); Danish Council for Strategic Research (Grant no 0603‐00280B) and The Capital Region Research Foundation have provided core support to the COPSAC research center
Publisher Copyright:
©2021 European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.